Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Recruiting · NCT06317805 · Registry updated 2024-03-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 4 | 2024-03-19 | NCT06317805 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aixial s.r.o. | 1 |
| ANOVA CRO s.r.o. | 1 |
| AOP Orphan Pharmaceuticals AG | 5 |
| GCP-Service International Ltd. & Co. KG | 2 |
| PharmaLex Belgium | 1 |
19 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.